CYCS and cardiac hypertrophy: In this experiment, we commenced nicorandil treatment at 20 weeks of age, when no release of cytochrome c from mitochondria had been observed although reduced cardiac function, cardiac hypertrophy, and cardiac fibrosis had already been observed in R120G TG mice.